Genetic analysis of capsular status of meningococcal carrier isolates

Epidemiology and Infection

Volumn 130, Issue 1, 2003, Pages 59-70

  Sadler, F ^a   Fox, A ^a   Neal, K ^b   Dawson, M ^c   Cartwright, K ^d   Borrow, R ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^d GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; SIALIC ACID;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BASE MISPAIRING; BLOOD GROUP TYPING; COMMUNITY CARE; CONTROLLED STUDY; DISEASE CARRIER; DOWN REGULATION; EPIDEMIC; GENE CONTROL; GENE INSERTION SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HEALTH PROGRAM; HUMAN; INFECTION RISK; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; POLYMERASE CHAIN REACTION; VACCINATION;

BACTERIAL CAPSULES; BASE SEQUENCE; DISEASE OUTBREAKS; DNA PRIMERS; DNA, BACTERIAL; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MENINGITIS, MENINGOCOCCAL; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION;

EID: 0037329073     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268802007987     Document Type: Article

References (19)

1. Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99: 591-601.
2. Stephens DS, Spellman PA, Swartley JS. Effect of the (a2→8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J Infect Dis 1993; 167: 475-9.
3. Virji M, Makepeace K, Ferguson DJP, Achtman M, Moxon ER. Meningococcal Opa and Opc proteins: their role in colonisation and invasion of human epithelial and endothelial cells. Mol Microbiol 1993; 10: 499-510.
4. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986; 18: 25-34.
5. Frosch M, Weisgerber C, Meyer TF. Molecular characterisation and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Nat Acad Sci USA 1989; 86: 1669-73.
6. Hammerschmidt S, Muller A, Sillmann H, et al. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialytransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 1996; 20: 1211-20.
7. Hammerschmidt S, Hilse R, van Putten JPM, Gerardy-Schan R, Unkmeir A, Frosch M. Modulation of cell-surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 1996; 15: 192-8.
8. Tzeng Y-L, Swartley JS, Miller YK, et al. Transcriptional regulation of divergent capsule biosynthesis and transport operon promoters in serogroup B Neisseria meningitidis. Infect Immun 2001; 69: 2502-11.
9. Von Loewenich FD, Wintermeyer E, Dumig M, Frosch M. Analysis of transcriptional control mechanisms of capsular expression in Neisseria meningitidis. Int J Med Microbiol 2001; 291: 361-9.
10. Porritt RJ, Mercer JL, Munro R. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology 2000; 32: 42-5.
11. Guiver M, Borrow R, Marsh J, et al. Evaluation of the Applied Biosystems Automated Taqman PCR system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 2000; 20: 173-9.
12. Frosch M, Muller D, Bousset K, Muller A. Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression. Infect Immun 1992; 60: 798-803.
13. Neal KR, Irwin DJ, Davies S, Kaczmarski EB, Wale MC. Sustained reduction in the carriage of Neisseria meningitidis as a result of a community meningococcal disease control programme. Epidemiol Infect 1998; 121: 487-93.
14. Eldridge J, Sutcliffe EM, Abbott JD. Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by co-agglutination. Med Lab Sci 1978; 35: 63-6.
15. Borrow R, Claus H, Chaudry U, et al. SiaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett 1998; 159: 209-14.
16. Borrow R, Claus H, Guiver M, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialytransferase (siaD) PCR ELISA. Epidemiol Infect 1997; 118: 111-7.
17. Fox AJ, Jones DM, Gray SJ, Caugant DA, Saunders NA. An epidemiologically valuable typing method for Neisseria meningitidis by analysis of restriction length fragment polymorphism. J Med Microbiol 1991; 34: 265-70.
18. Anonymous. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-5): 1-10.
19. Sivonen A, Renkonen O-V, Weskström P, Koskenvuo K, Raunio V, Mäkelä PH. The effect of chemoprophylatic use of rifampicin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis 1978; 137: 238-44.